相关实验视频

Updated: Jan 7, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

在治疗类杀虫剂中毒的维生素K₁治疗期间使用里瓦罗克萨班

Jean Escal^1,2, Angélique Drague¹, Géraldine Poenou^2,3

¹Laboratoire de pharmacologie et toxicologie, Centre Hospitalier Universitaire de Saint-Etienne, France.

Research and practice in thrombosis and haemostasis

|December 26, 2025

概括

直接口服抗凝剂 (DOAC) 可以在维生素K1 (VK1) 治疗中安全地重新引入,用于长期抗凝剂杀剂 (LAAR) 中毒. 这种方法有助于高血栓形成风险的患者,平衡抗凝剂需求与杀鼠剂中毒管理.

科学领域:

毒理学毒理学毒理学
药理学药理学是指药理学的学科.
内部医学内部医学

背景情况:

严重的抗凝血剂杀鼠剂中毒需要维生素K1 (VK1) 治疗.
长效抗凝血剂杀剂 (LAARs) 通常需要长时间的VK1治疗.
患者可能因其他疾病而接受直接口服抗凝剂 (DOAC).

研究的目的:

研究在接受长期VK1治疗的LAAR中毒患者中安全地重新引入DOAC的可行性.
评估在DOAC上患有复发性血栓塞的患者的管理,该患者经历了严重的LAAR中毒.

主要方法:

一个患有复发性血栓塞的患者的病例报告,他接受了里瓦洛克萨班治疗,并摄入了多种LAAR.
由于严重的VK依赖性凝血病 (INR>26) 和出血症,停止服用里瓦罗克萨班.
开始静脉注射和口服VK1治疗,然后在监测下成功地重新引入里瓦罗克萨班.

主要成果:

患者患有严重的凝血病,需要进行广泛的VK1治疗.
在患者仍然接受口服VK1治疗时,利瓦罗克萨班成功地重新引入治疗.
密切的临床和实验室监测对于安全的DOAC重新引入至关重要.

结论:

在LAAR中毒的VK1治疗期间恢复DOAC治疗是可行的.
这一案例突出了管理患有血栓形成风险和杀剂中毒的患者的潜在策略.
在这种临床场景中重新引入DOAC时,必须仔细监测.

关键词:

布罗迪法库姆 (brodifacoum) 是一种制泡.案例报告案例报告不同的白.甲氨酸 (Difethialone) 是一种多甲氨酸.这是一种中毒,中毒.里瓦罗克萨班 (Rivaroxaban) 是一个杀动物杀虫剂杀动物杀虫剂

更多相关视频

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...

Prevention of Further Absorption of Poison

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...